Quanta Dialysis Technologies

Quanta has developed an advanced haemodialysis system for use in the
home and clinic. Our proprietary  cartridge-based system, SC+, is a
portable and compact providing clinical efficacy utilising high flow
rates typically used on traditional machines. SC+ is designed to offer
ease-of-use and flexibility, facilitating self-care and supporting
dialysis patients across the entire continuum of care.

Quanta is privately owned and based in Alcester, UK. The Company was
founded in 2008 as a spin out from the FTSE 100 engineering company IMI
plc, with funding provided by a group of leading venture capital
investors specialised in healthcare: Air Liquide, b-to-v Partners AG,
IMI, Kuwait Life Sciences Company, NBGI Ventures, Seroba Kernel
LifeSciences, Seventure Partners and Wellington Partners.

Company Growth (employees)
Warwickshire, GB
Size (employees)
78 (est)+2%
Quanta Dialysis Technologies was founded in 2008 and is headquartered in Warwickshire, GB

Key People/Management at Quanta Dialysis Technologies

John Milad

John Milad

CEO & Founder
Willem Baralt

Willem Baralt

Chief Financial Officer
Clive Buckberry

Clive Buckberry

Chief Technology Officer
Peter Hoyer

Peter Hoyer

Chief Commercial Officer
Rolf Wildeman

Rolf Wildeman

Chief of Operations
Amit Bose

Amit Bose

Chief Engineer

Quanta Dialysis Technologies Office Locations

Quanta Dialysis Technologies has an office in Warwickshire
Warwickshire, GB (HQ)
Tything Road
Show all (1)

Quanta Dialysis Technologies Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$57.5 m

Latest funding size

$2.9 m

Time since last funding

over 2 years


Quanta Dialysis Technologies's latest funding round in August 2015 was reported to be $2.9 m. In total, Quanta Dialysis Technologies has raised $57.5 m

Quanta Dialysis Technologies Financials

Quanta Dialysis Technologies's revenue was reported to be £453.3 k in FY, 2013 which is a 208% increase from the previous period.

Net income (FY, 2016)

(12.1 m)

EBITDA (FY, 2016)

(10 m)

EBIT (FY, 2016)

(10.2 m)

Cash (31-Dec-2016)

6.5 m
GBPFY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


44.9 k355.5 k147.2 k453.3 k

Operating expense total

3.2 m4.3 m5.5 m7.9 m


(2.5 m)(3 m)(3.7 m)(5.1 m)(7.1 m)(7.2 m)(10 m)

EBITDA margin, %

GBPFY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


3.5 m4.8 m723.4 k992 k1.2 m8.2 m7.4 m6.5 m

Accounts Receivable

44.9 k54.6 k56.2 k14.4 k


109.2 k16.2 k

Current Assets

3.6 m5 m907.1 k1 m1.7 m8.9 m8.5 m7.9 m
    GBPFY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    (1.6 m)(3.1 m)(4 m)(5.4 m)(7.7 m)(7.8 m)(7.5 m)(12.1 m)

    Cash From Operating Activities

    (6.2 m)(7.5 m)(9.4 m)

    Cash From Financing Activities

    13.4 m7.1 m9 m

    Net Change in Cash

    7.1 m(841.3 k)(827 k)
      Y, 2016

      Financial Leverage

      -1.2 x
      Show all financial metrics

      Quanta Dialysis Technologies's Web-traffic and Trends

      Quanta Dialysis Technologies Online and Social Media Presence

      Quanta Dialysis Technologies Company Life and Culture

      You may also be interested in